Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

HPV testing for cervical cancer 'the best option for women over 30'

Testing for the presence of DNA from the human papillomavirus (HPV) alongside conventional smear test is the best cervical cancer screening option for all women aged 30...

Trial finds new drug combo increases remission time for lymphoma patients

A trial led by French researchers has found that patients under 60 with a form of non-Hodgkin's lymphoma called 'diffuse large B-cell lymphoma' are more likely to have a...

Nottingham scientist builds Phortress against breast cancer

A new type of anti-cancer drug with a unique mechanism that selectively targets breast cancer cells will enter clinical trials in the New Year, a leading Cancer Research...

Study confirms long term benefits of tamoxifen

Taking tamoxifen for 10 rather than five years halves the risk of women dying from the most common kind of breast cancer.

Cancer Research UK to investigate new drug combination in lung cancer

Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who...

Clinical trials set to test new cancer treatment

A new cancer treatment based on white blood cells called granulocytes is to be tested on humans in a phase II clinical trial at Wake Forest University Baptist Medical...

US government approves prostate cancer treatment vaccine

The US Food and Drug Administration (FDA) has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.

'Targeted' breast and ovarian cancer drug could have far wider application

Canadian researchers have shown that the targeted cancer drug olaparib can also reduce the size of tumours in a substantial minority of ovarian cancer patients.

Vision for 2020 launched as ten-year survival for cancer doubles in 30 years

Ten-year survival for all types of cancer combined has reached 46.2 per cent, new statistics from Cancer Research UK reveal today.

More research needed on complementary therapies

A Cancer Research UK scientist has called for more clinical trials to evaluate the benefits of complementary therapies for cancer patients.